Zdrowie i gospodarka · 13/01/2017

FDA Releases Draft Guidance on Multiple Endpoints in Clinical Trials

The FDA has published a draft guidance for industry on managing multiple endpoints in clinical trials, aiming to help sponsors and review staff accurately analyze study results and avoid drawing incorrect conclusions about a drug's effectiveness.